Trends in motor neuron disease: association with latitude and air lead levels in Spain

被引:19
|
作者
Santurtun, Ana [1 ]
Villar, Alejandro [2 ]
Delgado-Alvarado, Manuel [3 ]
Riancho, Javier [4 ]
机构
[1] Univ Cantabria, Dept Physiol & Pharmacol, Unit Legal Med, Ave Cardenal Herrera Oria S-N, Santander 39011, Spain
[2] Ticnor SL, Santander, Spain
[3] Biodonostia Hlth Res Inst, Neurodegenerat Dis Area, San Sebastian, Spain
[4] Univ Hosp Marques de Valdecilla IDIVAL CIBERNED, Serv Neurol, Santander, Spain
关键词
ALS; Motor neuron disease; Lead; AMYOTROPHIC-LATERAL-SCLEROSIS; EPIDEMIOLOGY; EXPOSURE;
D O I
10.1007/s10072-016-2581-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Motor neuron diseases (MND) are a group of disorders characterized by motor neuron degeneration. Among them, amyotrophic lateral sclerosis (ALS) is by far the most common in adulthood. This paper assesses the trend and geographical pattern in MND incidence in Spain and the possible air lead levels effect on this pathology. To confirm this concept, we performed a retrospective analysis of the deaths due to MND in Spain during 2000 and 2013, determined the geographical differences, and explored the relationship between MND and the air levels of lead. Overall, between 2000 and 2013, 11,355 people died in Spain because of MND. Disease mortality significantly increased in recent years (2007-2013) when compared with the first time of the period. Spearman's rank correlation coefficient also showed a statistically significant positive trend (CC = 0.824, p = 0.0002). Among people over 65 years, mortality rates were higher in Northern provinces. Moreover, we found a significant association of MND mortality with higher air lead levels (CC = 0.457, p = 0.01). Our study confirms that MND mortality is increasing in Spain, with a significant latitude gradient, which suggests an important role of environmental exposures. This ecological study suggests that air lead levels may be implicated in ALS pathogenesis.
引用
收藏
页码:1271 / 1275
页数:5
相关论文
共 45 条
  • [31] Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocytochemistry in canine motor neuron disease
    Green, SL
    Vulliet, PR
    Pinter, MJ
    Cork, LC
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (11) : 1070 - 1077
  • [32] Association Between Early-Life and Premorbid Measurements of Body Composition and Risk of Motor Neuron Disease: A Prospective Cohort Study in the UK Biobank
    Joyce, Emily E.
    Xu, Shishi
    Ingre, Caroline
    Potenza, Rosa Luisa
    Seitz, Christina
    Yang, Huazhen
    Zeng, Yu
    Song, Huan
    Fang, Fang
    ANNALS OF NEUROLOGY, 2024, : 259 - 269
  • [33] URINARY-EXCRETION OF LEAD AND MERCURY AFTER ORAL-ADMINISTRATION OF MESO-2,3-DIMERCAPTOSUCCINIC ACID IN PATIENTS WITH MOTOR-NEURON DISEASE
    LOUWERSE, ES
    BUCHET, JP
    VANDIJK, MA
    DEJONG, VJMB
    LAUWERYS, RR
    INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1995, 67 (02) : 135 - 138
  • [34] THE EFFECT OF URBAN POLLUTION ON LEAD LEVELS IN AIR OF THE CITY OF VALENCIA (SPAIN) - MAY-1989 OCTOBER-1990
    MOLTO, JC
    VIANA, E
    PICO, Y
    FONT, G
    SCIENCE OF THE TOTAL ENVIRONMENT, 1995, 162 (2-3) : 111 - 117
  • [35] A case report of motor neuron disease in a patient showing significant level of DDTs, HCHs and organophosphate metabolites in hair as well as levels of hexane and toluene in blood
    Kanavouras, Konstantinos
    Tzatzarakis, Manolis N.
    Mastorodemos, Vasileios
    Plaitakis, Andreas
    Tsatsakis, Aristidis M.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 256 (03) : 399 - 404
  • [36] CSF AND PLASMA AMINO-ACID LEVELS IN MOTOR-NEURON DISEASE - ELEVATION OF CSF GLUTAMATE IN A SUBSET OF PATIENTS
    SHAW, PJ
    FORREST, V
    INCE, PG
    RICHARDSON, JP
    WASTELL, HJ
    NEURODEGENERATION, 1995, 4 (02): : 209 - 216
  • [37] Elevated levels of transcripts encoding a human retroviral envelope protein (syncytin) in muscles from patients with motor neuron disease
    Oluwole, O. Steven A.
    Yao, Yuanrong
    Conradi, Sebastian
    Kristensson, Krister
    Karlsson, Hakan
    AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (02): : 67 - 72
  • [38] Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression - A longitudinal study
    Spoerndly-Nees, Soeren
    Jakobsson Larsson, Birgitta
    Zetterberg, Lena
    Akerblom, Ylva
    Nyholm, Dag
    Asenloef, Pernilla
    PALLIATIVE & SUPPORTIVE CARE, 2024, 22 (05) : 1150 - 1157
  • [39] Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature
    Nanetti, Lorenzo
    Fancellu, Roberto
    Tomasello, Chiara
    Gellera, Cinzia
    Pareyson, Davide
    Mariotti, Caterina
    JOURNAL OF NEUROLOGY, 2009, 256 (11) : 1926 - 1928
  • [40] C9ORF72 familial motor neuron disease - frontotemporal dementia associated with lung adenocarcinoma and anti-Ma2/Ta antibodies: a chance association?
    Geevasinga, N.
    Burrell, J. R.
    Hibbert, M.
    Vucic, S.
    Ng, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (04) : E31 - E33